GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Syneos Health Inc (FRA:8IN) » Definitions » Price-to-Owner-Earnings

Syneos Health (FRA:8IN) Price-to-Owner-Earnings : 39.22 (As of May. 04, 2024)


View and export this data going back to 2015. Start your Free Trial

What is Syneos Health Price-to-Owner-Earnings?

As of today (2024-05-04), Syneos Health's share price is €40.00. Syneos Health's Owner Earnings per Share (TTM) ended in Jun. 2023 was €1.02. It's Price-to-Owner-Earnings for today is 39.22.


The historical rank and industry rank for Syneos Health's Price-to-Owner-Earnings or its related term are showing as below:

FRA:8IN' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 8.04   Med: 24.51   Max: 707.46
Current: 39.06

During the past 12 years, the highest Price-to-Owner-Earnings of Syneos Health was 707.46. The lowest was 8.04. And the median was 24.51.


FRA:8IN's Price-to-Owner-Earnings is not ranked
in the Medical Diagnostics & Research industry.
Industry Median: 25.185 vs FRA:8IN: 39.06

As of today (2024-05-04), Syneos Health's share price is €40.00. Syneos Health's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Jun. 2023 was €0.71. Therefore, Syneos Health's PE Ratio for today is 56.10.

As of today (2024-05-04), Syneos Health's share price is €40.00. Syneos Health's EPS without NRI for the trailing twelve months (TTM) ended in was €0.71. Therefore, Syneos Health's PE Ratio without NRI for today is 56.10.

During the past 12 years, Syneos Health's highest PE Ratio without NRI was 1500.43. The lowest was 11.61. And the median was 33.77.


Syneos Health Price-to-Owner-Earnings Historical Data

The historical data trend for Syneos Health's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Syneos Health Price-to-Owner-Earnings Chart

Syneos Health Annual Data
Trend Dec13 Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 15.79 30.21 20.52 32.72 10.92

Syneos Health Quarterly Data
Sep18 Dec18 Mar19 Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 25.23 13.01 10.92 13.09 37.70

Competitive Comparison of Syneos Health's Price-to-Owner-Earnings

For the Diagnostics & Research subindustry, Syneos Health's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Syneos Health's Price-to-Owner-Earnings Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Syneos Health's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Syneos Health's Price-to-Owner-Earnings falls into.



Syneos Health Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Syneos Health's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=40.00/1.02
=39.22

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Syneos Health  (FRA:8IN) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Syneos Health Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Syneos Health's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Syneos Health (FRA:8IN) Business Description

Traded in Other Exchanges
N/A
Address
1030 Sync Street, Morrisville, NC, USA, 27560-5468
Syneos is a global contract research and outsourced commercialization organization that provides services to pharmaceutical and biotechnology firms. Its clinical solutions segment offers early- to late-stage clinical trial support that ranges from specialized staffing models to strategic partnerships that oversee nearly all aspects of a drug program, while the company's commercialization solutions includes outsourced sales, consulting, public relations, and advertising services.

Syneos Health (FRA:8IN) Headlines

No Headlines